You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tocilizumab

Showing 51 - 75 of 243
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tocilizumab, COVID-19, Critical Care Trial in Trabzon (Tocilizumab)

Completed
  • Tocilizumab
  • +3 more
  • Tocilizumab
  • Trabzon, Turkey
    Karadeniz Technical University
May 18, 2021

Tocilizumab in Patients With Severe COVID-19

Recruiting
  • Severe COVID 19 Pneumonia
  • Tocilizumab
  • Tocilizumab
  • Ciudad autónoma de Buenos Aires, Caba, Argentina
    Hospital Italiano de Buenos AIres
Jun 10, 2021

Granulomatosis With Polyangiitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Paris (Rituximab,

Not yet recruiting
  • Granulomatosis With Polyangiitis
  • Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
  • Paris, France
    Hôpital de la Croix Saint Simon
Oct 10, 2022

COVID-19, Hospitalized COVID-19 Patients Trial in Zgharta, Tripoli (Lopinavir / Ritonavir, Remdesivir (RDV), Tocilizumab)

Recruiting
  • COVID-19
  • Hospitalized COVID-19 Patients
  • Lopinavir / Ritonavir
  • +3 more
  • Zgharta, North, Lebanon
  • +1 more
Jun 28, 2023

Giant Cell Arteritis Trial in Bern (Tocilizumab, Glucocorticoids)

Completed
  • Giant Cell Arteritis
  • Bern, Switzerland
    University Hospital Bern, Inselspital
Jun 21, 2021

Kidney Transplantation, Graft Failure Trial in Toulouse (Tocilizumab)

Recruiting
  • Kidney Transplantation
  • Graft Failure
  • Tocilizumab
  • Toulouse, France
    CHU Toulouse
Mar 15, 2022

COVID-19, Pneumonia, Viral Trial in Spain (Tocilizumab, Pembrolizumab (MK-3475))

Terminated
  • COVID-19
  • Pneumonia, Viral
  • Tocilizumab
  • Pembrolizumab (MK-3475)
  • Barcelona, Spain
  • +6 more
Jun 14, 2022

Solid Tumor Trial in Chuo Ku (SAIL66, Tocilizumab)

Not yet recruiting
  • Solid Tumor
  • Chuo Ku, Tokyo, Japan
    National Cancer Center Hospital
Feb 9, 2023

Lymphoblastic Leukemia, Acute, Childhood Trial in Philadelphia (Tocilizumab, CART 19)

Completed
  • Lymphoblastic Leukemia, Acute, Childhood
  • Tocilizumab
  • CART 19
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jun 30, 2021

Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Tocilizumab)

Recruiting
  • Adamantinomatous Craniopharyngioma
  • Recurrent Adamantinomatous Craniopharyngioma
  • Tocilizumab
  • Aurora, Colorado
  • +17 more
Jan 8, 2023

Prostate Adenocarcinoma, Prostate Cancer, Localized Prostate Cancer Trial in San Francisco, Saint Louis (Atezolizumab,

Recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • San Francisco, California
  • +1 more
Oct 8, 2022

Renal Cell Carcinoma, NSCLC, Pancreatic Adenocarcinoma, Colorectal Cancer Trial (RO7515629, tocilizumab)

Not yet recruiting
  • Renal Cell Carcinoma, Non-small Cell Lung Cancer, Pancreatic Adenocarcinoma, Colorectal Cancer
  • (no location specified)
Mar 3, 2023

Lymphoma Trial in Beijing, Shanghai City, Seoul (Obinutuzumab, Glofitamab, Rituximab)

Recruiting
  • Lymphoma
  • Beijing, China
  • +2 more
Oct 12, 2023

Giant Cell Arteritis, Neurovascular Disorder Trial in Paris (Tocilizumab, Placebo)

Not yet recruiting
  • Giant Cell Arteritis
  • Neurovascular Disorder
  • Tocilizumab
  • Placebo
  • Paris, France
    Saint Antoine Hospital, Neurology Unit, Assistance Publique-Hôpi
May 14, 2021

Idiopathic Retroperitoneal Fibrosis Trial in Beijing (Tocilizumab, Glucocorticoids)

Recruiting
  • Idiopathic Retroperitoneal Fibrosis
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Mar 17, 2021

Arthritis, Rheumatoid, Interaction Trial in Esbjerg, Odense, Sønderborg (Tocilizumab, Sarilumab)

Terminated
  • Arthritis, Rheumatoid
  • Interaction
  • Esbjerg, Region Of Southern Denmark, Denmark
  • +2 more
Jan 20, 2023

Relapsing Polychondritis Trial in Ottawa (Tocilizumab)

Completed
Has Results
  • Relapsing Polychondritis
  • Tocilizumab
  • Ottawa, Ontario, Canada
    Children's Hospital of Eastern Ontario
Feb 11, 2021

Multiple Myeloma Trial in Nashville (Cevostamab, Tocilizumab)

Recruiting
  • Multiple Myeloma
  • Nashville, Tennessee
    Tennessee Onc., PLLC - SCRI
Sep 8, 2022

Multiple Myeloma Trial in Athens (Cevostamab, XmAb24306, Tocilizumab)

Recruiting
  • Multiple Myeloma
  • Athens, Greece
  • +1 more
Jan 2, 2023

Late Complication From Kidney Transplant Trial in San Francisco (Tocilizumab)

Completed
Has Results
  • Late Complication From Kidney Transplant
  • Tocilizumab
  • San Francisco, California
    University of California, San Francisco
Mar 5, 2021

Cytokine Release Syndrome, Stem Cell Transplant Complications Trial in Monterrey (Tocilizumab)

Completed
  • Cytokine Release Syndrome
  • Stem Cell Transplant Complications
  • Tocilizumab
  • Monterrey, Nuevo Leon, Mexico
    Hospital Universitario Dr. Jose E Gonzalez UANL
Mar 5, 2021

Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Chiba, Tokyo (RO7616789, Tocilizumab)

Recruiting
  • Small Cell Lung Cancer
  • Neuroendocrine Carcinoma
  • Chiba, Japan
  • +1 more
Jan 16, 2023

Mature B-Cell Non-Hodgkin Lymphoma Trial (Obinutuzumab, Glofitamab, Rituximab)

Not yet recruiting
  • Mature B-Cell Non-Hodgkin Lymphoma
  • (no location specified)
Sep 6, 2022

COVID-19 Trial in Spain (Tocilizumab, Hydroxychloroquine, Azithromycin)

Recruiting
  • COVID-19
  • Tocilizumab
  • +2 more
  • Oviedo, Asturias, Spain
  • +6 more
May 3, 2021

Multiple Myeloma Trial in Korea, Republic of, Poland, Spain (Cevostamab, Lenalidomide, Tocilizumab)

Not yet recruiting
  • Multiple Myeloma
  • Seoul, Korea, Republic of
  • +4 more
Jan 11, 2023